Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. 2004

Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
Departamento de Ingeniería Genética de Plantas, Centro de Investigación y de Estudios Avanzados del I.P.N., Unidad Irapuato. Km 9.6 Libramiento Norte Carretera Irapuato-León, Apdo. Postal 629, Irapuato, Guanajuato, México 36500.

Interleukin 12 (IL-12) is a key heterodimeric cytokine produced by a variety of antigen-presenting cells, including dendritic cells, macrophages, and B cells. It displays a potent array of biological activities affecting natural killer (NK) and T cells. These activities include promotion of cell-mediated or type 1 T helper cell responses (Th1). Due to that property, IL-12 has been employed in cancer immunotherapy, in mouse models of infectious diseases and in airway inflammation, and it may also have utility as a vaccine adjuvant. Transgenic plants are being used in many laboratories around the world for the production of therapeutically valuable proteins and as vehicles for oral vaccines. Here we present the expression of a single-chain human interleukin-12 in transgenic tobacco plants. The biological activity of plant-produced IL-12 was determined by interferon gamma (IFN-gamma) production by natural killer (NK) cells, and the level of production was comparable to that obtained with commercially available recombinant IL-12. The potential use of this recombinant protein is discussed.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014026 Nicotiana A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; the dried leaves of Nicotiana tabacum are used for SMOKING. Tobacco Plant,Nicotiana tabacum,Plant, Tobacco,Plants, Tobacco,Tobacco Plants
D015202 Protein Engineering Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes. Genetic Engineering of Proteins,Genetic Engineering, Protein,Proteins, Genetic Engineering,Engineering, Protein,Engineering, Protein Genetic,Protein Genetic Engineering
D018506 Gene Expression Regulation, Plant Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants. Plant Gene Expression Regulation,Regulation of Gene Expression, Plant,Regulation, Gene Expression, Plant
D018664 Interleukin-12 A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS. Edodekin Alfa,IL-12,Natural Killer Cell Stimulatory Factor,Cytotoxic Lymphocyte Maturation Factor,IL 12,IL-12 p70,IL12,Interleukin 12,Interleukin-12 p70,Interleukin 12 p70

Related Publications

Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
January 2001, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
December 2005, Transgenic research,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
June 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
June 2013, Transgenic research,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
October 2003, Biotechnology letters,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
January 2004, Doklady. Biochemistry and biophysics,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
April 1999, Bioscience, biotechnology, and biochemistry,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
November 1993, Plant molecular biology,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
August 2000, Applied and environmental microbiology,
Abel Gutiérrez-Ortega, and Federico Avila-Moreno, and Luis Jorge Saucedo-Arias, and Carmen Sánchez-Torres, and Miguel Angel Gómez-Lim
March 2005, Vaccine,
Copied contents to your clipboard!